Naloxol
Подписчиков: 0, рейтинг: 0
| |||
| Names | |||
|---|---|---|---|
|
IUPAC names
α-naloxol: (4R,4aS,7S,7aR,12bS)-3-allyl-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol
β-naloxol: (4R,4aS,7R,7aR,12bS)-3-allyl-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol | |||
| Identifiers | |||
|
|||
|
3D model (JSmol)
|
|
||
| ChemSpider | |||
| ECHA InfoCard | 100.236.696 | ||
|
PubChem CID
|
|||
| UNII |
|
||
|
CompTox Dashboard (EPA)
|
|||
| |||
| |||
| Properties | |||
| C19H23NO4 | |||
| Molar mass | 329.396 g·mol−1 | ||
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |||
Naloxol is an opioid antagonist closely related to naloxone. It exists in two isomeric forms, α-naloxol and β-naloxol.
α-naloxol is a human metabolite of naloxone. Synthetically, α-naloxol can be prepared from naloxone by reduction of the ketone group, and β-naloxol can be prepared from α-naloxol by a Mitsunobu reaction.
Naloxol can be said to be the oxymorphol analogue of naloxone.